Your browser doesn't support javascript.
loading
Contribution of SHANK3 mutations to autism spectrum disorder.
Moessner, Rainald; Marshall, Christian R; Sutcliffe, James S; Skaug, Jennifer; Pinto, Dalila; Vincent, John; Zwaigenbaum, Lonnie; Fernandez, Bridget; Roberts, Wendy; Szatmari, Peter; Scherer, Stephen W.
Afiliación
  • Moessner R; The Centre for Applied Genomics, The Hospital for Sick Children, Toronto, Ontario, M5G 1L7, Canada.
Am J Hum Genet ; 81(6): 1289-97, 2007 Dec.
Article en En | MEDLINE | ID: mdl-17999366
Mutations in SHANK3, which encodes a synaptic scaffolding protein, have been described in subjects with an autism spectrum disorder (ASD). To assess the quantitative contribution of SHANK3 to the pathogenesis of autism, we determined the frequency of DNA sequence and copy-number variants in this gene in 400 ASD-affected subjects ascertained in Canada. One de novo mutation and two gene deletions were discovered, indicating a contribution of 0.75% in this cohort. One additional SHANK3 deletion was characterized in two ASD-affected siblings from another collection, which brings the total number of published mutations in unrelated ASD-affected families to seven. The combined data provide support that haploinsufficiency of SHANK3 can cause a monogenic form of autism in sufficient frequency to warrant consideration in clinical diagnostic testing.
Asunto(s)

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Variación Genética / Proteínas Portadoras / Mutación Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Revista: Am J Hum Genet Año: 2007 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Variación Genética / Proteínas Portadoras / Mutación Tipo de estudio: Clinical_trials Límite: Female / Humans / Male Idioma: En Revista: Am J Hum Genet Año: 2007 Tipo del documento: Article País de afiliación: Canadá